RecruitingNot ApplicableNCT06978777
Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity
Sponsor
University Hospital, Basel, Switzerland
Enrollment
12 participants
Start Date
Jan 21, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of the study is to asses brown adipose tissue activity after a cold mild stimulus, preceded by 200mg caffeine or placebo administration.
Eligibility
Min Age: 18 YearsMax Age: 40 Years
Inclusion Criteria4
- BMI 18.5 to 25 kg/m2
- Able to give informed consent as documented by signature
- Moderate caffeine consumption (1 to 3 cups of coffee per day)
- Increase of EE in response to mild cold of ≥ 5% of REE
Exclusion Criteria16
- Known hypersensitivity or allergy to caffeine
- Concomitant medication other than prescription free analgesics (paracetamol and NSAID) and oral contraceptives
- Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, cardiac arrhythmia, hypertension, diabetes mellitus, hyper- or hypothyroidism)
- History of depressive disorder or anxiety disorder
- Smoker / habitual tobacco use
- Habitual excessive alcohol use
- Regular consumption of caffeine containing energy drinks
- Weight change of \>5% within 3 months prior to inclusion
- Systolic blood pressure \>140 mmHg and/or diastolic blood pressure \> 95 mmHg.
- Resting heart rate \>90 bpm
- Hypersensitivity to cold (e.g. Raynaud syndrome)
- Known or suspected non-compliance, drug or alcohol abuse
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant.
- Enrolment of the investigator, his/her family members, employees, and other dependent persons
- Enrolment into another study using ionizing radiation within the previous 12 months.
- Pregnancy or lactation
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGCaffeine (200 mg)
single dose of 200mg caffeine orally in study visit A
DRUGPlacebo
single dose of 1 tablet Placebo in study visit B
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06978777
Related Trials
Energy Dense Fueling for Cold-Weather Operations
NCT074896901 location
Molecular, Cellular, and Genetic Characterization of Human Adipose Tissue and Its Role in Metabolism
NCT026928851 location
Intermittent Cold Exposure and Brown Adipose Tissue Hyperplasia
NCT070484051 location
Omega-3 Fatty Acids as Regulators of Brown Adipose Tissue During Cold Exposure
NCT058221411 location
Thermogenic Silencer Regulatory Factors in Humans
NCT064241321 location